Wonpoong

Wonpoong Pharm is a South Korean pharmaceutical company established in 1986 that specializes in the development, manufacturing, and marketing of ethical (ETC) and over-the-counter (OTC) medicines. The company maintains a robust portfolio focusing on therapeutic areas such as respiratory, circulatory, digestive, and metabolic disorders. Wonpoong operates advanced manufacturing facilities in Hwaseong that are compliant with KGMP standards. The firm invests in research and development to produce high-quality generics and incrementally modified drugs (IMDs) to improve patient outcomes. Publicly traded on the KOSDAQ exchange, Wonpoong is known for its stable market presence and commitment to healthcare innovation in the domestic Korean market.